Parameters | HT patients (n = 100) |
---|---|
Anti-hypertensive drugs | |
Betablockers | 24, 24% |
Angiotensin-Converting-Enzyme Inhibitors | 35, 35% |
Angiotensin II Receptor Antagonists | 43, 43% |
Calcium Channel Blockers | 56, 56% |
Thiazide and Thiazide-like Diuretics | 62, 62% |
Treatment strategies | |
Monotherapy | 30, 30% |
Dual Therapy | 27, 27% |
Triple Therapy | 36, 36% |
Quadruple Therapy | 7, 7% |